HIV pill for prevention debated as FDA ruling nears| Reuters

Full Story »

Posted by Sally Lehrman
Stats Help
# Tweets: 17 (as of 2012-03-12)
Editorial Help
Posted by: Posted by Sally Lehrman - Mar 12, 2012 - 9:52 PM PDT
Content Type: Article
Edit Lock: This story can be edited

Reviews

Show All | Notes | Comments | Quotes | Links
Christopher Caruso
4.0
by Christopher Caruso - Sep. 23, 2012

This article had many sources from those oppose and are proponents for this HIV pill. However, the article did not cite an actual potential user as to how they viewed the risks, advantages or even if they trusted it. This should have been included in order to complete the context that this pill is currently being scrutinized for.

The problem cited in this story is the widespread occurence of HIV, and that there is currently no cure for this fatal disease. Reuters cited Truvada, a pill made by Gileal, as proposed to curb the spread of the disease. However, the AIDS Healthcare Foundation states that Truvada can cause kidney problems as well as other complications. Furthermore, it may cause HIV to adapt to Truvada and thus evolve and become even more deadly. For these reasons (in addition for the hope ... More »

See Full Review » (5 answers)
Riley McKay
3.8
by Riley McKay - Mar. 13, 2012

This article considers both the medical and the personal frames: Medical in that it is a drug that is being considered to help stop the spread of this disease and personal in that it is a personal responsibility to take the pill every single day. This article also frames the responsible party as the individuals who are continuously engaging in unsafe or risky behavior. This is not a solution I have encountered in my reporting and I have actually not heard of this as a solution at all. It is interesting to see both sides of this idea: On one hand, the spread of HIV/AIDS is so detrimental to populations that a medical way of halting the spread of it would be extremely beneficial. Contrastingly so, tProxy-Connection: keep-alive ... More »

See Full Review » (11 answers)

Comments on this story Help (BETA)

NT Rating | My Rating

Ratings

3.8

not enough reviews
from 2 reviews (3% confidence)
Quality
4.0
Information
4.0
Insight
4.0
Style
4.0
Context
4.0
Depth
4.0
Expertise
4.0
Originality
4.0
Relevance
4.0
Popularity
2.9
Recommendation
3.0
Credibility
3.0
# Reviews
1.0
# Views
4.8
# Likes
1.0
# Emails
1.0
More
How our ratings work »

Topics

(See these related stories.)

Links Help

No links yet. Please review this story to add some!